Melatonin modulates estrogen signaling in estrogen synthesis by reducing the gonadotropin action, disrupting the activation of estradiol receptors on breast tumors, regulating the enzymes involved in the biosynthesis of estrogens in other tissues, resulting in reduced estrogen-dependent tumor growth, and potentially reducing the risk of hormone receptor-positive breast cancer27. The gene discussed is ESR1; the disease is breast neoplasm.